-logo-1200x675.jpg&w=240&h=240&zc=2){kind=logo}
What is B. Riley’s Estimate for MDGL FY2028 Earnings?
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Free Report) – Investment analysts at B. Riley issued their FY2028 EPS estimates for shares of Madrigal Pharmaceuticals in a research note issued on Thursday, May 1st. B. Riley analyst M. Mamtani forecasts that the biopharmaceutical company will earn $42.69 per share for the year. B. Riley has a “Buy” […]
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Free Report) – Investment analysts at B. Riley issued their FY2028 EPS estimates for shares of Madrigal Pharmaceuticals in a research note issued on Thursday, May 1st. B. Riley analyst M. Mamtani forecasts that the biopharmaceutical company will earn $42.69 per share for the year. B. Riley has a “Buy” […]
